Table 3.
Category | Subcategory | Description | Examples (related clinical case) |
---|---|---|---|
Appropriate | • A drug therapy is defined as appropriate if the correct drug, dose, dosage, duration, and route is chosen according to the European and/or local guidelines | • amoxicillin 500mg three times a day for 5 days per os (CAPa) | |
Suboptimal | • The dose of drug therapy is slightly too high (half to two times the normal dose) for the condition being treated | • esomeprazole 40mg once daily (GERDb) | |
• The dose of drug therapy is slightly too low for the condition being treated to produce the desired outcome | • paracetamol 1000mg twice daily (osteoarthritisc) | ||
• The duration of drug therapy is slightly too long for the condition being treated | • amoxicillin 14 days therapy (CAP) | ||
• The duration of drug therapy is slightly too short for the condition being treated to produce the desired outcome | • omeprazole 3 weeks (GERD) | ||
• Second or third choice of drug is prescribed instead of first‐choice drug for the condition being treated (according to the local or (inter)national guidelines) | • ranitidine instead of omeprazole (GERD) | ||
• Symptomatic drug therapy is prescribed without strong scientific benefits for the patient | • acetylcysteine (bronchitisd) | ||
Inappropriate | Not immediately harmful | • The drug dose is too high (three times to four times the normal dose) for the condition being treated | • enalapril 20 mg once daily (hypertensione) |
• The drug dose is too low for the condition being treated to expect a beneficial outcome | • amoxicillin 375mg once daily (CAP) | ||
• The duration of the drug therapy is too long for the condition being treated resulting in drug overuse | • omeprazole life‐long (GERD) | ||
• The duration of the drug therapy is too short for the condition being treated to produce the desired outcome | • valsartan 1 week (hypertension) | ||
• Incorrect drug formulation for route of drug administration | • ceftriaxone per os (CAP) | ||
• No drug therapy is prescribed although the condition requires initiation of drug therapy | • no additional analgesic prescribed (osteoarthritis) | ||
• Omission of protective or preventive drug therapy | • NSAID without PPI (osteoarthritis) | ||
• Unnecessary drug therapy is prescribed for which there is no valid medical indication | • amoxicillin (bronchitis) | ||
• Duplicate drug therapy is prescribed without benefits for the patient | • two times salbutamol (bronchitis) | ||
• The prescription lacked drug name, dose, dosage, duration, route, or included inappropriate abbreviations, or drug class instead of generic name, or was illegible | • ‘PPI’ (GERD) | ||
Potentially harmful | • The drug dose is too high (four to ten times the normal dose) for the condition being treated with increased risk of adverse effects | • tramadol 500 mg once daily (osteoarthritis) | |
• Unnecessary drug therapy is prescribed for which there is no valid medical indication and with increased risk of adverse effects | • amitriptyline (osteoarthritis) | ||
• Intravenous drug therapy is prescribed while not medically necessary | • ceftriaxone intravenous (CAP) | ||
• Duplicate drug therapy is prescribed with increased risk of adverse effects | • two times ibuprofen (osteoarthritis) | ||
• Drug therapy could exacerbate the patient's condition including drug‐drug interaction or drug‐disease contraindication | • propranolol and asthma (hypertension) | ||
Potentially lethal | • Serum drug levels are likely to be toxic based on common dosage guidelines | • naproxen 50 g (osteoarthritis) | |
• Errors including decimal points or units resulting in severe toxicity | • salbutamol 200 mg (bronchitis) | ||
• Drug therapy being administered has a high potential to cause cardiopulmonary arrest in the dose ordered | • amlodipine 300 mg (hypertension) |
CAP, mild community‐acquired pneumonia (pneumonia severity index I).
GERD, gastroesophageal reflux disease (grade A) not sufficiently responding to lifestyle changes.
Osteoarthritis not sufficiently responding to treatment with paracetamol.
Uncomplicated acute bronchitis.
Essential hypertension not sufficiently responding to hydrochlorothiazide 12.5 mg daily and lifestyle changes.